Currently submitted to: JMIR Formative Research
Date Submitted: Feb 25, 2026
Open Peer Review Period: Mar 6, 2026 - May 1, 2026
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Real-Time AI-Augmented Fluoroscopic Navigation for Intraoperative Pulmonary Nodule Localization: Prospective Evaluation of a Digital Surgical Decision Support System
ABSTRACT
Background:
The integration of artificial intelligence (AI) into intraoperative surgical imaging represents an emerging frontier in digital health. Despite advances in preoperative computed tomography (CT)–based surgical planning, real-time translation of imaging data into actionable intraoperative guidance remains limited by CT-to-body divergence—a fundamental information gap between preoperative digital models and the dynamic surgical field. This divergence, driven by lung deflation under anesthesia and positional changes, represents a critical digital-to-physical registration challenge that current preoperative imaging workflows fail to address in real time. This study evaluated the performance and safety of the LungVision system, a portable AI-driven digital platform that integrates preoperative CT data with real-time fluoroscopic image fusion, for intraoperative tumor localization during thoracoscopic lung resection.
Objective:
This study aimed to evaluate the clinical feasibility, localization accuracy, and safety of the LungVision system—an AI-augmented fluoroscopic navigation platform—for real-time intraoperative localization of small pulmonary nodules during thoracoscopic surgery.
Methods:
A prospective single-center study enrolled fourteen patients with pulmonary nodules requiring localization prior to thoracoscopic resection between March and September 2024. The platform comprises a passive radiopaque positioning board, an AI-powered computing unit for real-time image processing, and a tablet-based interface for procedural planning and augmented visualization. All patients received dual localization with either preoperative CT-guided dye injection or Archimedes virtual bronchoscopic navigation, followed by intraoperative localization with the LungVision system and video-assisted thoracoscopic surgery. Demographic data, lesion characteristics, procedural performance, and procedure-related complications were collected.
Results:
The mean patient age was 57.2 years, and 92.9% were non-smokers. Most nodules were peripherally located (85.7%), with a mean diameter of 9.3 ± 5.3 mm and a mean CT attenuation of −320.1 Hounsfield units. LungVision successfully localized all target lesions intraoperatively, with a mean navigation time of 38.6 minutes. Complete resection was achieved in all cases, and 71.4% of nodules were pathologically malignant. No intraoperative or localization-related complications were observed. The system was integrated into the existing operating room without additional infrastructure modifications.
Conclusions:
The LungVision system demonstrated high accuracy and safety for intraoperative localization of small, hypodense pulmonary nodules. By minimizing CT-to-body divergence and integrating seamlessly into existing bronchoscopic and surgical workflows, this AI-driven platform represents a scalable and infrastructure-light alternative to conventional localization strategies, warranting further evaluation for broader clinical implementation.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.